Back to Search
DEBRA SILBERG, MD
MD
Gastroenterology Physician
NPI: 1477625903Individual
Specialties, Licenses & Credentials
Clinical Trials (1)
1
Linked Trials
0
Recruiting
0
With Results
Research & Publications (20)
Cdx2 ectopic expression induces gastric intestinal metaplasia in transgenic mice.
PMID 11875002·Gastroenterology·2002
7-preclinical
Cdx1 and cdx2 expression during intestinal development.
PMID 11040183·Gastroenterology·2000
7-preclinical
Clinical trial: intragastric acid control in patients who have Barrett's oesophagus--comparison of once- and twice-daily regimens of esomeprazole and lansoprazole.
PMID 19438416·Aliment Pharmacol Ther·2009
4-observational
Induction of intestinalization in human esophageal keratinocytes is a multistep process.
PMID 18845559·Carcinogenesis·2009
8-other
Predictors of heartburn resolution and erosive esophagitis in patients with GERD.
PMID 19601705·Curr Med Res Opin·2009
2-rct
Cdx1 and c-Myc foster the initiation of transdifferentiation of the normal esophageal squamous epithelium toward Barrett's esophagus.
PMID 18953412·PLoS One·2008
4-observational
Randomized, double-blind, placebo-controlled trial of the 5-HT1A receptor antagonist AZD7371 tartrate monohydrate (robalzotan tartrate monohydrate) in patients with irritable bowel syndrome.
PMID 18775020·Am J Gastroenterol·2008
4-observational
The homeodomain transcription factor Cdx1 does not behave as an oncogene in normal mouse intestine.
PMID 18231635·Neoplasia·2008
7-preclinical
Relationship between intragastric acid control and healing status in the treatment of moderate to severe erosive oesophagitis.
PMID 17305763·Aliment Pharmacol Ther·2007
4-observational
Intragastric acid control in non-steroidal anti-inflammatory drug users: comparison of esomeprazole, lansoprazole and pantoprazole.
PMID 16611280·Aliment Pharmacol Ther·2006
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3400 SPRUCE ST
PHILADELPHIA, PA 19104 - Phone
- (215) 349-8222
Quick Facts
- NPI
- 1477625903
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Clinical Trials
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile